Swarajya

Our View
HeadlinesMagazineVideosBooksस्वराज्यEconomyCultureEvents
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief
  • Subscriber login
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief

vaccine

Indian Vaccine Giant Serum Institute Eyes Global Expansion, Mulls Setting Up Its First Manufacturing Plant In Africa
Indian Vaccine Giant Serum Institute Eyes Global Expansion, Mulls Setting Up Its First Manufacturing Plant In AfricaSwarajya StaffMay 24, 2022 11:08 AM +05:30 IST
Covid-19 Vaccination For Children Aged 12 To 14 Is Expected To Begin In March: NTAGI Chief
Covid-19 Vaccination For Children Aged 12 To 14 Is Expected To Begin In March: NTAGI ChiefBhaswati Guha Majumder Jan 17, 2022 05:48 PM +05:30 IST
Emails Reveal That Anthony Fauci And Ex-NIH Director Francis Collins Shut Down Differing Views Among American Scientific Community On Covid-19 Response
Emails Reveal That Anthony Fauci And Ex-NIH Director Francis Collins Shut Down Differing Views Among American Scientific Community On Covid-19 ResponseBhaswati Guha Majumder Dec 27, 2021 04:59 PM +05:30 IST
WHO Cautions Against 'Dismissing Omicron As Mild', Reveals It Is Spreading At 'Unprecedented Rate'
WHO Cautions Against 'Dismissing Omicron As Mild', Reveals It Is Spreading At 'Unprecedented Rate'Bhaswati Guha Majumder Dec 15, 2021 04:42 PM +05:30 IST
Scientific Experts Will Take The Call On Rollout Of Booster And Covid Vaccines For Children: Mansukh Mandaviya
Scientific Experts Will Take The Call On Rollout Of Booster And Covid Vaccines For Children: Mansukh Mandaviya Bhaswati Guha Majumder Dec 6, 2021 04:05 PM +05:30 IST
Bharat Biotech's Intranasal Covid-19 Vaccine Completes Phase 2 Trials: Krishna Ella
Bharat Biotech's Intranasal Covid-19 Vaccine Completes Phase 2 Trials: Krishna EllaBhaswati Guha Majumder Nov 29, 2021 06:23 PM +05:30 IST
WHO's Soumya Swaminathan Explains Global Covid Surge, India's Situation, And Shares Details On Covax Supply
WHO's Soumya Swaminathan Explains Global Covid Surge, India's Situation, And Shares Details On Covax SupplyBhaswati Guha Majumder Nov 16, 2021 06:04 PM +05:30 IST
No Free Covid-19 Treatment For Patients Who Are ‘Unvaccinated By Choice’ In Singapore
No Free Covid-19 Treatment For Patients Who Are ‘Unvaccinated By Choice’ In SingaporeBhaswati Guha Majumder Nov 12, 2021 02:44 PM +05:30 IST
Booster Doses? Vaccination For Children? SUTRA Team Answers Your Questions
Booster Doses? Vaccination For Children? SUTRA Team Answers Your QuestionsThe SUTRA TeamNov 10, 2021 11:43 AM +05:30 IST
Kerala High Court Calls PM's Photo Removal From Covid Vaccine Certificate Appeal 'Dangerous'
Kerala High Court Calls PM's Photo Removal From Covid Vaccine Certificate Appeal 'Dangerous'Bhaswati Guha Majumder Nov 3, 2021 06:57 PM +05:30 IST
FDA Okays Pfizer-BioNTech's Covid-19 Vaccine For Children Aged 5 To 11
FDA Okays Pfizer-BioNTech's Covid-19 Vaccine For Children Aged 5 To 11Bhaswati Guha Majumder Oct 30, 2021 04:27 PM +05:30 IST
US Biotech Company Ocugen Files IND Application With FDA For Bharat Biotech's Covaxin Clinical Trials
US Biotech Company Ocugen Files IND Application With FDA For Bharat Biotech's Covaxin Clinical TrialsBhaswati Guha Majumder Oct 28, 2021 02:33 PM +05:30 IST
Status Update: India's Covid-19 Situation At The Beginning Of The Festive Season
Status Update: India's Covid-19 Situation At The Beginning Of The Festive SeasonBhaswati Guha Majumder Oct 9, 2021 03:31 PM +05:30 IST
A Major Breakthrough: WHO Approves World's First Vaccine Against Malaria
A Major Breakthrough: WHO Approves World's First Vaccine Against Malaria Bhaswati Guha Majumder Oct 7, 2021 01:06 PM +05:30 IST
Serum Institute Receives Approval To Launch Covovax Trials On Children Aged 7-11
Serum Institute Receives Approval To Launch Covovax Trials On Children Aged 7-11Bhaswati Guha Majumder Sep 29, 2021 04:37 PM +05:30 IST
China Shows Support For Waiving Intellectual Property Rights For Covid Vaccines At United Nations
China Shows Support For Waiving Intellectual Property Rights For Covid Vaccines At United NationsBhaswati Guha Majumder Sep 29, 2021 04:34 PM +05:30 IST
3D Printed Vaccine Patch Could Revolutionise Immunisation Process
3D Printed Vaccine Patch Could Revolutionise Immunisation ProcessBhaswati Guha Majumder Sep 27, 2021 05:57 PM +05:30 IST
New Deal Between Serum Institute Of India And Biocon Covers Vaccines, Other Biotech Products
New Deal Between Serum Institute Of India And Biocon Covers Vaccines, Other Biotech ProductsBhaswati Guha Majumder Sep 24, 2021 05:59 PM +05:30 IST
Explained: UK’s Newly Updated Travel Guidelines Did Not Make It Easier For Indian Travellers
Explained: UK’s Newly Updated Travel Guidelines Did Not Make It Easier For Indian TravellersBhaswati Guha Majumder Sep 23, 2021 02:11 PM +05:30 IST
'We Want Vaccines': WHO Chief Recommends Moratorium On Covid Boosters For Rest Of The Year
'We Want Vaccines': WHO Chief Recommends Moratorium On Covid Boosters For Rest Of The YearBhaswati Guha Majumder Sep 9, 2021 04:35 PM +05:30 IST
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Advertise
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype